78 related articles for article (PubMed ID: 35353984)
1. Benchmarking multi-ancestry prostate cancer polygenic risk scores in a real-world cohort.
Shah Y; Kulm S; Nauseef JT; Chen Z; Elemento O; Kensler KH; Sharaf RN
PLoS Comput Biol; 2024 Apr; 20(4):e1011990. PubMed ID: 38598551
[TBL] [Abstract][Full Text] [Related]
2. An early-onset specific polygenic risk score optimizes age-based risk estimate and stratification of prostate cancer: population-based cohort study.
Cheng Y; Wu L; Xin J; Ben S; Chen S; Li H; Zhao L; Wang M; Cheng G; Du M
J Transl Med; 2024 Apr; 22(1):366. PubMed ID: 38632662
[TBL] [Abstract][Full Text] [Related]
3. Breast and prostate cancer risk: The interplay of polygenic risk, rare pathogenic germline variants, and family history.
Hassanin E; May P; Aldisi R; Spier I; Forstner AJ; Nöthen MM; Aretz S; Krawitz P; Bobbili DR; Maj C
Genet Med; 2022 Mar; 24(3):576-585. PubMed ID: 34906469
[TBL] [Abstract][Full Text] [Related]
4. Cases in Precision Medicine: The Role of Polygenic Risk Scores in Breast Cancer Risk Assessment.
Zeinomar N; Chung WK
Ann Intern Med; 2021 Mar; 174(3):408-412. PubMed ID: 33253037
[TBL] [Abstract][Full Text] [Related]
5. Genomic risk scores in prostate cancer: polygenic yes, but are they poly-ancestral?
Basu A; Rais-Bahrami S
J Natl Cancer Inst; 2024 May; 116(5):635-636. PubMed ID: 38366849
[No Abstract] [Full Text] [Related]
6. Stakeholder Perception of the Implementation of Genetic Risk Testing for Twelve Multifactorial Diseases.
Tokutomi T; Yoshida A; Fukushima A; Nagami F; Minoura Y; Sasaki M
Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38254940
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in polygenic scores: translation, equitability, methods and FAIR tools.
Xiang R; Kelemen M; Xu Y; Harris LW; Parkinson H; Inouye M; Lambert SA
Genome Med; 2024 Feb; 16(1):33. PubMed ID: 38373998
[TBL] [Abstract][Full Text] [Related]
8. Combined CRISPRi and proteomics screening reveal a cohesin-CTCF-bound allele contributing to increased expression of RUVBL1 and prostate cancer progression.
Tian Y; Dong D; Wang Z; Wu L; Park JY; ; Wei GH; Wang L
Am J Hum Genet; 2023 Aug; 110(8):1289-1303. PubMed ID: 37541187
[TBL] [Abstract][Full Text] [Related]
9. Aspartoacylase suppresses prostate cancer progression by blocking LYN activation.
Weng H; Xiong KP; Wang W; Qian KY; Yuan S; Wang G; Yu F; Luo J; Lu MX; Yang ZH; Liu T; Huang X; Zheng H; Wang XH
Mil Med Res; 2023 Jun; 10(1):25. PubMed ID: 37271807
[TBL] [Abstract][Full Text] [Related]
10. Implementing Reporting Standards for Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease.
Smith JL; Schaid DJ; Kullo IJ
Curr Atheroscler Rep; 2023 Jun; 25(6):323-330. PubMed ID: 37223852
[TBL] [Abstract][Full Text] [Related]
11. Risk-Stratified Screening for Colorectal Cancer Using Genetic and Environmental Risk Factors: A Cost-Effectiveness Analysis Based on Real-World Data.
van den Puttelaar R; Meester RGS; Peterse EFP; Zauber AG; Zheng J; Hayes RB; Su YR; Lee JK; Thomas M; Sakoda LC; Li Y; Corley DA; Peters U; Hsu L; Lansdorp-Vogelaar I
Clin Gastroenterol Hepatol; 2023 Dec; 21(13):3415-3423.e29. PubMed ID: 36906080
[TBL] [Abstract][Full Text] [Related]
12. Polygenic risk for prostate cancer: Decreasing relative risk with age but little impact on absolute risk.
Schaid DJ; Sinnwell JP; Batzler A; McDonnell SK
Am J Hum Genet; 2022 May; 109(5):900-908. PubMed ID: 35353984
[TBL] [Abstract][Full Text] [Related]
13. Validation of a multi-ancestry polygenic risk score and age-specific risks of prostate cancer: A meta-analysis within diverse populations.
Chen F; Darst BF; Madduri RK; Rodriguez AA; Sheng X; Rentsch CT; Andrews C; Tang W; Kibel AS; Plym A; Cho K; Jalloh M; Gueye SM; Niang L; Ogunbiyi OJ; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Mensah JE; Adjei AA; Diop H; Lachance J; Rebbeck TR; Ambs S; Gaziano JM; Justice AC; Conti DV; Haiman CA
Elife; 2022 Jul; 11():. PubMed ID: 35801699
[TBL] [Abstract][Full Text] [Related]
14. Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.
Darst BF; Shen J; Madduri RK; Rodriguez AA; Xiao Y; Sheng X; Saunders EJ; Dadaev T; Brook MN; Hoffmann TJ; Muir K; Wan P; Le Marchand L; Wilkens L; Wang Y; Schleutker J; MacInnis RJ; Cybulski C; Neal DE; Nordestgaard BG; Nielsen SF; Batra J; Clements JA; Cancer BioResource AP; Grönberg H; Pashayan N; Travis RC; Park JY; Albanes D; Weinstein S; Mucci LA; Hunter DJ; Penney KL; Tangen CM; Hamilton RJ; Parent MÉ; Stanford JL; Koutros S; Wolk A; Sørensen KD; Blot WJ; Yeboah ED; Mensah JE; Lu YJ; Schaid DJ; Thibodeau SN; West CM; Maier C; Kibel AS; Cancel-Tassin G; Menegaux F; John EM; Grindedal EM; Khaw KT; Ingles SA; Vega A; Rosenstein BS; Teixeira MR; ; Kogevinas M; Cannon-Albright L; Huff C; Multigner L; Kaneva R; Leach RJ; Brenner H; Hsing AW; Kittles RA; Murphy AB; Logothetis CJ; Neuhausen SL; Isaacs WB; Nemesure B; Hennis AJ; Carpten J; Pandha H; De Ruyck K; Xu J; Razack A; Teo SH; ; Newcomb LF; Fowke JH; Neslund-Dudas C; Rybicki BA; Gamulin M; Usmani N; Claessens F; Gago-Dominguez M; Castelao JE; Townsend PA; Crawford DC; Petrovics G; Casey G; Roobol MJ; Hu JF; Berndt SI; Van Den Eeden SK; Easton DF; Chanock SJ; Cook MB; Wiklund F; Witte JS; Eeles RA; Kote-Jarai Z; Watya S; Gaziano JM; Justice AC; Conti DV; Haiman CA
Am J Hum Genet; 2023 Jul; 110(7):1200-1206. PubMed ID: 37311464
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry Composition.
Hughes E; Wagner S; Pruss D; Bernhisel R; Probst B; Abkevich V; Simmons T; Hullinger B; Judkins T; Rosenthal E; Roa B; Domchek SM; Eng C; Garber J; Gary M; Klemp J; Mukherjee S; Offit K; Olopade OI; Vijai J; Weitzel JN; Whitworth P; Yehia L; Gordon O; Pederson H; Kurian A; Slavin TP; Gutin A; Lanchbury JS
JCO Precis Oncol; 2022 Nov; 6():e2200084. PubMed ID: 36331239
[TBL] [Abstract][Full Text] [Related]
16. Implementation and implications for polygenic risk scores in healthcare.
Slunecka JL; van der Zee MD; Beck JJ; Johnson BN; Finnicum CT; Pool R; Hottenga JJ; de Geus EJC; Ehli EA
Hum Genomics; 2021 Jul; 15(1):46. PubMed ID: 34284826
[TBL] [Abstract][Full Text] [Related]
17. Towards clinical utility of polygenic risk scores.
Lambert SA; Abraham G; Inouye M
Hum Mol Genet; 2019 Nov; 28(R2):R133-R142. PubMed ID: 31363735
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
